GLP-1s are now the most consumerised medication today, said PwC UK head of retail and partner in the firms Strategy& consulting wing Jacqueline Windsor
Truveta Research found that for every 1,000 patients with a first-time GLP-1 prescription, 42 were diagnosed with type 2 diabetes within 15 days in 2024, up from 32 in 2020
The higher dose, Trulicity 1.5mg/0.5ml, costs $289.99 for a box of four pens
Reduced stress-related eating Stress is a common reason for overeating and can lead to weight gain over time
The study cohort included more than 132,500 and 201,100 incident users of GLP-1s and sulfonylureas, respectively
Clinical trials show that patients who stop semaglutide often regain 50% of lost weight within one year, which is why many physicians recommend continued use for weight maintenance